Total Positions
68
Quarter
2024 Q4
Top Holding
RVMD (9.5%)
Top 10 Concentration
54.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 68
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RVMD
Revolution Medi...
|
Healthcare | 9.52% | 9.52% |
#1
Prev: #1
|
3.8 | no change | no change |
P
S
|
4,279,464 | $194,073,692 | 2020 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TYRA
Tyra Bioscience...
|
Healthcare | 7.44% | 7.44% |
#2
Prev: #2
|
3.0 | no change | no change |
P
S
|
6,448,359 | $151,600,920 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
NUVL
Nuvalent Inc
|
Healthcare | 5.62% | 5.62% |
#3
Prev: #3
|
2.2 | no change | no change |
P
S
|
1,120,192 | $114,595,642 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ONC
BeiGene Ltd
|
Healthcare | 5.51% | 5.51% |
#4
Prev: #4
|
2.2 | no change | no change |
P
S
|
500,000 | $112,255,000 | 2016 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
CYTK
Cytokinetics In...
|
Healthcare | 5.44% | 5.44% |
#5
Prev: #5
|
2.2 | no change | no change |
P
S
|
2,100,000 | $110,880,000 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SWTX
Springworks The...
|
Unknown | 5.38% | 5.38% |
#6
Prev: #6
|
2.2 | no change | no change |
P
S
|
3,421,541 | $109,626,174 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
MRUS
Merus N V
|
Healthcare | 4.66% | 4.66% |
#7
Prev: #7
|
1.9 | no change | no change |
P
S
|
1,900,000 | $94,924,000 | 2020 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
SRPT
Sarepta Therape...
|
Healthcare | 3.98% | 3.98% |
#8
Prev: #8
|
1.6 | no change | no change |
P
S
|
650,000 | $81,178,500 | 2018 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RNA
Avidity Bioscie...
|
Healthcare | 3.89% | 3.89% |
#9
Prev: #9
|
1.6 | no change | no change |
P
S
|
1,727,388 | $79,338,931 | 2020 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IDYA
Ideaya Bioscien...
|
Healthcare | 3.42% | 3.42% |
#10
Prev: #10
|
1.4 | no change | no change |
P
S
|
2,202,812 | $69,785,084 | 2019 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TNGX
Tango Therapeut...
|
Healthcare | 3.10% | 3.10% |
#11
Prev: #11
|
1.2 | no change | no change |
P
S
|
8,198,642 | $63,129,543 | 2021 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ARGX
Argenx SE
|
Healthcare | 2.66% | 2.66% |
#12
Prev: #12
|
1.1 | no change | no change |
P
S
|
100,000 | $54,208,000 | 2019 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
APLS
Apellis Pharmac...
|
Healthcare | 2.44% | 2.44% |
#13
Prev: #13
|
1.0 | no change | no change |
P
S
|
1,726,000 | $49,777,840 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AKRO
Akero Therapeut...
|
Healthcare | 2.36% | 2.36% |
#14
Prev: #14
|
0.9 | no change | no change |
P
S
|
1,676,733 | $48,105,470 | 2019 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ANAB
AnaptysBio Inc
|
Healthcare | 2.14% | 2.14% |
#15
Prev: #15
|
0.9 | no change | no change |
P
S
|
1,300,000 | $43,550,000 | 2017 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
AXSM
Axsome Therapeu...
|
Healthcare | 1.76% | 1.76% |
#16
Prev: #16
|
0.7 | no change | no change |
P
S
|
400,000 | $35,948,000 | 2020 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
ITOS
iTeos Therapeut...
|
Unknown | 1.48% | 1.48% |
#17
Prev: #17
|
0.6 | no change | no change |
P
S
|
2,946,915 | $30,088,002 | 2020 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
LEGN
Legend Biotech ...
|
Healthcare | 1.43% | 1.43% |
#18
Prev: #18
|
0.6 | no change | no change |
P
S
|
600,000 | $29,238,000 | 2023 Q2 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
GERN
Geron Corp
|
Healthcare | 1.34% | 1.34% |
#19
Prev: #19
|
0.5 | no change | no change |
P
S
|
6,000,000 | $27,240,000 | 2022 Q4 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
THRD
Third Harmonic ...
|
Unknown | 1.33% | 1.33% |
#20
Prev: #20
|
0.5 | no change | no change |
P
S
|
2,000,000 | $27,100,000 | 2022 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RCKT
Rocket Pharmace...
|
Healthcare | 1.33% | 1.33% |
#21
Prev: #21
|
0.5 | no change | no change |
P
S
|
1,466,051 | $27,077,962 | 2018 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
RCUS
Arcus Bioscienc...
|
Healthcare | 1.20% | 1.20% |
#22
Prev: #22
|
0.5 | no change | no change |
P
S
|
1,602,200 | $24,497,638 | 2019 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
TIL
Instil Bio Inc
|
Healthcare | 1.17% | 1.17% |
#23
Prev: #23
|
0.5 | no change | no change |
P
S
|
355,500 | $23,932,260 | 2024 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
XENE
Xenon Pharmaceu...
|
Healthcare | 1.16% | 1.16% |
#24
Prev: #24
|
0.5 | no change | no change |
P
S
|
600,000 | $23,622,000 | 2018 Q3 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) | |||
|
IMVT
Immunovant Inc
|
Healthcare | 1.15% | 1.15% |
#25
Prev: #25
|
0.5 | no change | no change |
P
S
|
825,000 | $23,520,750 | 2021 Q1 | 13F Filing | 2024-12-31 | 2025-02-14 (Est.) |
Showing 1-25 of 68 holdings